Neonc Technologies Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTHI research report →
Companywww.neonctech.com
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
- CEO
- Amir Farrokh Heshmatpour
- IPO
- 2025
- Employees
- 8
- HQ
- Calabasas, CA, US
Price Chart
Valuation
- Market Cap
- $108.37M
- P/E
- -3.27
- P/S
- 0.00
- P/B
- -9.54
- EV/EBITDA
- -3.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 284.28%
- ROIC
- 259.18%
Growth & Income
- Revenue
- $39.99K · 0.00%
- Net Income
- $-62,146,210 · 0.00%
- EPS
- $-3.23 · 0.00%
- Op Income
- $-58,169,198
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $12.99
- 52W Low
- $3.20
- 50D MA
- $6.11
- 200D MA
- $8.24
- Beta
- 0.19
- Avg Volume
- 65.45K
Get TickerSpark's AI analysis on NTHI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 24, 25 | Heshmatpour Amir F | buy | 6,000 |
| Nov 21, 25 | Heshmatpour Amir F | buy | 4,000 |
| Nov 21, 25 | Heshmatpour Amir F | buy | 20,000 |
| Nov 12, 25 | CHIANG MING-FU (ALAN) | other | 0 |
| Nov 12, 25 | CHIANG MING-FU (ALAN) | other | 0 |
| Nov 12, 25 | CHIANG MING-FU (ALAN) | other | 0 |
| Nov 12, 25 | CHIANG MING-FU (ALAN) | other | 0 |
| Nov 12, 25 | CHIANG MING-FU (ALAN) | other | 0 |
| Nov 20, 25 | Neman-Ebrahim Yousha | buy | 1,100 |
| Jun 5, 25 | Neman-Ebrahim Yousha | other | 0 |
Our NTHI Coverage
We haven't published any research on NTHI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NTHI Report →